“From an immune activation perspective, recent studies have found that patients with long COVID have complement dysregulation with signs of thromboinflammation, higher concentrations of circulating non-conventional monocytes associated with various chronic inflammatory conditions, and a T-cell phenotype consistent with T-helper-2-cell-skewed CD4+ T-cell activation.”